Notable Analyst Rating Changes 11/23: MDAS, VLO, RBC, RHT Upgraded; ACI, NOC, NFLX, HNT Downgraded
Tweet Send to a Friend
UPGRADES
Baird upgrades MedAssets (Nasdaq: MDAS) from Neutral to Outperform, boosting their price target from $21 to $25.
Benchmark ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird upgrades MedAssets (Nasdaq: MDAS) from Neutral to Outperform, boosting their price target from $21 to $25.
Benchmark ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
